NCT05694819 2026-04-08
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
National Cancer Center Hospital East
Phase 2 Completed
National Cancer Center Hospital East
Astellas Pharma Inc
European Organisation for Research and Treatment of Cancer - EORTC
Corcept Therapeutics
Janssen Pharmaceutical K.K.
NYU Langone Health
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca